Trifecta Capital Advisors, LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1962615 NORTHBROOK, IL

Position in TMO

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$6,017,322

+$110,115 QoQ

Shares Held

12,002

-0.1% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.89%

of 13F equity value

Holder Rank

#784

of 2,602 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Trifecta Capital Advisors, LLC holds $7,224,312 across 10 Diagnostics & Research names. TMO ranks #1 (83.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc. This page	12,002	$6,017,322
2	GRAL	GRAIL, Inc.	14,280	$974,895
3	NTRA	Natera, Inc.	595	$161,512
4	TWST	Twist Bioscience Corp	610	$62,756
5	WAT	Waters Corp /De/	13	$4,875
6	IDXX	Idexx Laboratories Inc /De	3	$1,579
7	DHR	Danaher Corp /De/	3	$571
8	A	Agilent Technologies, Inc.	3	$398

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,017,322	12,002	-0.1%	Shares	Sole	2026-08-03
2026-03-31	$5,907,207	12,018	+0.3%	Shares	Sole	2026-05-01
2025-12-31	$6,941,811	11,980	+1.5%	Shares	Sole	2026-01-30
2025-09-30	$5,723,721	11,801	-1.1%	Shares	Sole	2025-11-03
2025-06-30	$4,838,354	11,933	-0.5%	Shares	Sole	2025-07-23
2025-03-31	$5,967,716	11,993	-1.4%	Shares	Sole	2025-04-21
2024-12-31	$6,330,158	12,168	-0.3%	Shares	Sole	2025-02-04
2024-09-30	$7,551,502	12,208	+0.8%	Shares	Sole	2024-10-16
2024-06-30	$6,697,383	12,111	+5.3%	Shares	Sole	2024-08-07
2024-03-31	$6,685,658	11,503	+3.6%	Shares	Sole	2024-04-16
2023-12-31	$5,891,238	11,099	+1.7%	Shares	Sole	2024-01-25
2023-09-30	$5,524,339	10,914	+2.6%	Shares	Sole	2023-11-01
2023-06-30	$5,547,767	10,633	+3.6%	Shares	Sole	2023-08-14
2023-03-31	$5,918,167	10,268	+2.6%	Shares	Sole	2023-05-09
2022-12-31	$5,512,406	10,010	—	Shares	Sole	2023-01-18
No filing history on record for this holder in this stock.